GEHC Price Prediction Next Week
Analysis and Insights
To predict the stock price of GE HealthCare Technologies (GEHC) for the next trading week, we analyze both technical indicators and recent news sentiment.
Technical Analysis:
GEHC's stock has shown a bullish trend recently, with the price closing at $86.58 on March 7. Key technical indicators include:
- RSI (14): 45.69, indicating the stock is not overbought or oversold.
- MACD: Slightly bearish, but the stock is trading above its 20 and 50-day moving averages, signaling strength.
- Fibonacci Levels: Pivot at $87.51, with resistance at $91.14 and support at $83.89.
News Sentiment and Fundamental Analysis:
GEHC reported strong Q4 earnings, beating EPS estimates and showing revenue growth in key segments. The company expects 2-3% organic growth in 2025, supported by strong orders and margin expansion. Analysts have raised target prices, with an average of $100.28, indicating optimism.
Analyst Sentiment:
Analysts are bullish, with targets ranging up to $110. This reflects confidence in GEHC's growth and market position.
Price Prediction and Recommendation:
Based on technical indicators and positive sentiment, GEHC is expected to reach $91 next week. The stock is a buy as it approaches the Fibonacci resistance level, with a stop-loss at $83.89.
GEHC Similar Chart Price Prediction
The price of GEHC is predicted to go up -18.23%, based on the high correlation periods with AMSC. The similarity of these two price pattern on the periods is 94.51%.
GEHC
AMSC
Down: -18.23%Similarity: 94.51%
GEHC Revenue Forecast
GEHC EPS Forecast
GEHC FAQs
What is GEHC revenue forecast for next quarter？
What is GEHC eps forecast for next quarter？
GEHC Analyst's Forecast
Matthew Taylor
Jefferies
Hold → Strong Buy
2025-01-08
Price Target
$95 → $103
Upside
+19.41%
Jefferies upgraded GE HealthCare to Buy from Hold with a price target of $103, up from $95. The stock has pulled back and now trades at "just" 17-18 times estimated 2025 earnings, below GE HealthCare average, peers, and well off recent highs of 20 times, the analyst tells investors in a research note. The firm says the push out of China stimulus "has helped re-base expects, creating an entry point." GE is poised to gain share in healthy markets, contends Jefferies.
Larry Biegelsen
Wells Fargo
Buy
2024-10-31
Price Target
$95 → $96
Upside
+9.9%
Vijay Kumar
Evercore ISI Group
Buy
2024-10-01
Price Target
$98 → $102
Upside
+11.27%
